Highland Capital Management, LLC Guardant Health, Inc. Transaction History

Highland Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 16, 2020	SELL	$80.32 - $111.8 $1.8 Million - $2.5 Million	-22,393 Closed	0 $0
Q2 2020 Jul 22, 2020	SELL	$60.49 - $97.5 $123,399 - $198,900	-2,040 Reduced 8.35%	22,393 $1.82 Million
Q1 2020 May 05, 2020	BUY	$59.04 - $88.81 $1.44 Million - $2.17 Million	24,433 New	24,433 $1.7 Million

311

110M

2.51M

1.7M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.18B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Highland Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Highland Capital Management, LLC with notifications on news.